Getting your player ready...
Biotech startups striving to cure headline-grabbing diseases such as hantavirus and swine flu are stymied by the astronomical cost of clinical trials, columnist Al Lewis writes.
Search for cures requires big bucks
Biotech startups striving to cure headline-grabbing diseases such as hantavirus and swine flu are stymied by the astronomical cost of clinical trials, columnist Al Lewis writes.
